Sandra Demaria @DemariaLab_WCM

Translational tumor immunologist, breast cancer pathologist, passionate about cancer immunotherapy Joined July 2023

Tweets

106
Followers

88
Following

46
Likes

180

Sandra Demaria @DemariaLab_WCM

7 months ago

This account is not active. You can find me @sandrademarialab.bsky.social

0 0 0 73 0

CaixaResearch @CaixaResearch

11 months ago

¿Cómo avanzarán las inmunoterapias contra el cáncer de mama en los próximos 1⃣0⃣ años? 🔬 @deVisserKarin, @DemariaLab_WCM y @Casanova_Acebes nos traen algunas claves de lo hablado hace unos días en el @CNIOStopCancer-#CaixaResearch Frontiers Meeting.👇 saludentuvida.com/cancer-3/tres-…

0 3 11 911 1

Sandra Demaria @DemariaLab_WCM

9 months ago

Join the SITC Run Club for the 2025 AACR Runners for Research 5K Run/Walk in support of Cancer Research! do.nr/49dr11dl via @DonorDrive @gulleyj1 @JennGuerriero

0 1 2 377 0

Sandra Demaria @DemariaLab_WCM

10 months ago

Happy to be recognized by @Clarivate as a 2024 Highly Cited Researcher who has demonstrated significant influence in their field! #HighlyCited2024 clarivate.com/highly-cited-r…

0 0 2 99 0

Download Image

Kristopher Sarosiek @CellDeathLab

12 months ago

➡️Join us October 11th at the JBL Symposium to hear from leaders in radiation oncology and AI in medicine including @HugoAerts (@harvardmed) @DrRebeccaHowel1 (@MDAndersonNews) @DemariaLab_WCM (@WeillCornell) & @HenningWillers (@MGHCancerCenter)! Info: hsph.harvard.edu/jbl-center/jbl…

2 4 11 4K 0

Download Image

Journal for ImmunoTherapy of Cancer @jitcancer

11 months ago

September @sitcancer #JITC Reading List by Section Editor Sandra Demaria @DemariaLab_WCM @WeillCornell selection #4: FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment by @RockefellerUniv and @ChilesResearch…

0 4 7 782 3

Download Image

Immunorad @immunorad

11 months ago

Jalal Ahmed presented exciting insights into enhancing CAR T cell therapy in solid tumors in the last talk of this "Novel Approaches" session. His talk focused on how radiotherapy (RT) can improve the effectiveness of CAR T cells in solid tumors.

1 1 2 147 0

Immunorad @immunorad

11 months ago

🗺 To finish this second day of the Immunorad conference, Brian D. Brown presented exciting research on how tumor microenvironment (TME) composition impacts immunotherapy (IO) success.

1 1 2 101 0

Immunorad @immunorad

11 months ago

Dr. Sierra McDonald presented complementary findings from the P-RAD clinical trial and a genetically engineered TNBC mouse model:

1 1 2 84 0

Immunorad @immunorad

11 months ago

⭐ Exciting takeaways from Anguraj Sadanandam, Ph.D.'s talk on AI and single-cell data analysis. He began by discussing the challenges of data-driven algorithms, emphasizing that cancer evolution is multifactorial and requires diverse data inputs.

1 1 2 82 0

Immunorad @immunorad

11 months ago

Timothy Chan kicked off the "Cancer Immunogenomics and Radiation Therapy" session with a detailed talk emphasizing the need for biomarker identification to improve the efficacy of RT/IO combinations.

1 1 3 126 0

Immunorad @immunorad

11 months ago

⌚️To finish this session, Sean Pitroda presented extensive research on “Immunogenomic Responses to Combination SBRT and Immune Checkpoint Blockade in Metastatic NSCLC.” , from a recently published work originally from COSINR randomized phase I trial.

1 1 2 73 0

Immunorad @immunorad

11 months ago

Exciting updates from Gaorav Gupta on the P-RAD trial—the first randomized study comparing aPD-1 alone vs. aPD-1 + RT in early-stage, LN metastatic, TNBC, and high-risk HR-HER2- breast cancer:

1 1 1 61 1

Immunorad @immunorad

11 months ago

Great insights from Dr. Kristina Young’s talk on targeting TGF-β in rectal cancer, showing that TGF-β directly impact CD8+ T-cells anti-tumor efficacy

1 1 2 46 0

Immunorad @immunorad

11 months ago

🌟 Exciting Insights from Alan Melcher's talk on T Cell Dynamics and Radiotherapy in Rectal Cancer! 🌟 During his presentation, Prof. Melcher highlighted how a strong immune response to radiotherapy mimics viral infection.

1 1 3 57 1

Immunorad @immunorad

11 months ago

⭐️Kicking off the second day of ImunoRad, Anne-Gaëlle Goubet presented an exciting talk on leveraging Flash Radiotherapy for immune engagement and tumor control.

1 1 2 40 0

Immunorad @immunorad

11 months ago

Dr. Ben Chetrit stressed the need for developing innate immune strategies, particularly targeting Notch4 to reverse macrophage-related immunosuppression.

0 1 3 69 0

Immunorad @immunorad

11 months ago

"Radiation Therapy-Induced Modulation of the Tumor Immune Microenvironment" kicked off with insights from James Welsh on novel strategies to tackle checkpoint resistance.

1 1 4 63 0

Immunorad @immunorad

11 months ago

📷 Gut-Immune Axis: Healthy gut microbiome dysbiosis can enhance the immune system's ability to fight cancer cells 📷Low-dose #radiation: When combined with specific gut bacteria, can boost the response to immunotherapy and may drive the #abscopal effect. Prospective study inc

0 2 5 248 0

Immunorad @immunorad

11 months ago

Dr. @laurence Zigvogel's introductory presentation shed light on the revolutionary potential of the #gut #microbiome in combating cancer. 📷 #Antibiotics: Disrupting the delicate balance of gut bacteria with antibiotics can hinder the effectiveness of immunotherapy.